NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,900
-240 (-1.25%)
At close: Feb 27, 2026
60.71%
Market Cap 295.62B
Revenue (ttm) 129.81B
Net Income (ttm) 27.80B
Shares Out 15.64M
EPS (ttm) 1,777.18
PE Ratio 10.63
Forward PE 9.23
Dividend 750.00 (3.97%)
Ex-Dividend Date Dec 29, 2025
Volume 43,569
Average Volume 92,691
Open 19,140
Previous Close 19,140
Day's Range 18,770 - 19,220
52-Week Range 11,300 - 22,650
Beta 0.54
RSI 44.40
Earnings Date Feb 6, 2026

About NeoPharm CO., LTD.

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, So... [Read more]

Founded 2000
Employees 178
Stock Exchange KOSDAQ
Ticker Symbol 092730
Full Company Profile

Financial Performance

In 2024, NeoPharm CO., LTD.'s revenue was 119.01 billion, an increase of 22.56% compared to the previous year's 97.10 billion. Earnings were 23.06 billion, a decrease of -0.64%.

Financial Statements

News

There is no news available yet.